Downregulation of HDACs has been shown to assist in skeletal muscle insulin sensitivity and pharmacological inhibition of HDACs has been postulated as a viable therapeutic intervention for diabetes (Christensen et al. 2011; Dewanjee et al. 2021). Here, INS is linked to diabetes mellitus.